{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T19:10:41Z","timestamp":1777662641895,"version":"3.51.4"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1990,5,1]],"date-time":"1990-05-01T00:00:00Z","timestamp":641520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1990,5,1]],"date-time":"1990-05-01T00:00:00Z","timestamp":641520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1990,5]]},"DOI":"10.1007\/bf00177259","type":"journal-article","created":{"date-parts":[[2004,8,22]],"date-time":"2004-08-22T08:15:28Z","timestamp":1093162528000},"page":"199-200","source":"Crossref","is-referenced-by-count":28,"title":["Phase II study of Fludarabine Phosphate in multiple myeloma"],"prefix":"10.1007","volume":"8","author":[{"given":"Eric H.","family":"Kraut","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Crowley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Grever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Keppen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry E.","family":"Hynes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sydney E.","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00177259_CR1","first-page":"1405","volume":"40","author":"LW Dow","year":"1980","unstructured":"Dow LW, Bell DE, Poulakos L, Freidland A: Differences in metabolism and cytotoxicity between 9-\u03b2-D-Arabinofuranosyladenine and 9-\u03b2-D-arabinofuranosyl-2-fluoroadenine in human leukemic lymphoblasts. Cancer Res 40: 1405\u20131410, 1980","journal-title":"Cancer Res"},{"key":"BF00177259_CR2","first-page":"3610","volume":"40","author":"RW Brockman","year":"1980","unstructured":"Brockman RW, Cheng YC, Schabel FM Jr, Montgomery JA: Metabolism and chemotherapeutic activity of 9-\u03b2-D-arabinofuranosyl-2-fluoroadenine against murine L 1210 and evidence for its phosphorylation by deoxycytidine kinase. Cancer Res 40: 3610\u20133615, 1980","journal-title":"Cancer Res"},{"key":"BF00177259_CR3","first-page":"2711","volume":"47","author":"JM Leiby","year":"1987","unstructured":"Leiby JM, Snider KM, Kraut EH, Metz EN, Malspeis L, Grever MR: Phase II trial of 9-\u03b2-D-arabinofuranosyl-2-fIuoroadenine 5-monophosphate in non-Hodgkin's lymphoma. Prospective comparison of response with deoxycytidine kinase activity. Cancer Res 47: 2711\u20132719, 1987","journal-title":"Cancer Res"},{"key":"BF00177259_CR4","unstructured":"Grever MR, Coltman CA, Files JC, Greenberg BR, Hutton JJ, Talley RL, Von Hoff DD, Balcerzak SP: Fludarabine monophosphate in chronic lymphocytic leukemia. Blood 68, Vol. 5, Suppl #1, 223a, 1986"},{"key":"BF00177259_CR5","first-page":"842","volume":"36","author":"BM Durie","year":"1975","unstructured":"Durie BM, Salmon SE: A clinical staging system for multiple myeloma. Cancer Res 36: 842\u2013854, 1975","journal-title":"Cancer Res"},{"key":"BF00177259_CR6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF00203548","volume":"5","author":"PG Hurst","year":"1987","unstructured":"Hurst PG, Habib M, Garewal H, Bluestein M, Paquin M, Greenberg BR: Pulmonary toxicity associated with fludarabine monophosphate. Invest New Drugs 5: 207\u2013210, 1987","journal-title":"Invest New Drugs"},{"key":"BF00177259_CR7","unstructured":"Grever MR, Leiby JM, Kraut EH, Neidhart JA, Malspeis L, Balcerzak SP: A Phase I investigation of 2-Fluoro-Ara-AMP in refractory leukemia. Blood 64 (Suppl #1): 165a, 1984"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00177259.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00177259\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00177259","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00177259.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:17:09Z","timestamp":1678558629000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00177259"}},"subtitle":["A Southwest Oncology Group study"],"short-title":[],"issued":{"date-parts":[[1990,5]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1990,5]]}},"alternative-id":["BF00177259"],"URL":"https:\/\/doi.org\/10.1007\/bf00177259","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,5]]}}}